Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
1,932,424
-
Shares change
-
+209,183
-
Total reported value, excl. options
-
$17,120,867
-
Value change
-
+$1,950,325
-
Put/Call ratio
-
23.9%
-
Number of buys
-
24
-
Number of sells
-
-8
-
Price
-
$8.86
Significant Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q3 2021
47 filings reported holding ATNM - Actinium Pharmaceuticals, Inc. - Common Stock as of Q3 2021.
Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,932,424 shares
of 31,249,203 outstanding shares and own 6.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (866,731 shares), BlackRock Inc. (219,243 shares), GEODE CAPITAL MANAGEMENT, LLC (167,172 shares), BLAIR WILLIAM & CO/IL (82,366 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (79,166 shares), GSA CAPITAL PARTNERS LLP (68,205 shares), STATE STREET CORP (55,292 shares), Bank of New York Mellon Corp (50,793 shares), MORGAN STANLEY (43,972 shares), and NORTHERN TRUST CORP (38,329 shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.